{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:40:26Z","timestamp":1789148426043,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>In Deutschland leben ca.\u00a08\u202fMio. Menschen mit Diabetes mellitus. Eine Sp\u00e4tfolge dieser Erkrankung ist das diabetische Fu\u00dfsyndrom (DFS), dessen Pr\u00e4valenz stark ansteigt. Es umfasst alle Ver\u00e4nderungen am Fu\u00df als Folge der diabetischen Polyneuropathie sowie mikro- und makroangiopathischer (periphere arterielle Verschlusskrankheit, PAVK) Ver\u00e4nderungen. J\u00e4hrlich entstehen ca.\u00a0250.000 neue diabetische Fu\u00dfulzera. Diese werden oft zu chronischen Wunden. Trotz intensiver Bem\u00fchungen um Pr\u00e4vention, fr\u00fchzeitige Diagnostik und stadiengerechte Wundbehandlung werden in Deutschland j\u00e4hrlich ca.\u00a013.000 Majoramputationen bei Diabetikern durchgef\u00fchrt. Bei konsequenter Therapie des DFS in interdisziplin\u00e4ren Zentren mit Aussch\u00f6pfung aller M\u00f6glichkeiten der Wundbehandlung, der Druckentlastung sowie einer arteriellen Revaskularisation kann die Majoramputationsrate um bis zu 80\u202f% gesenkt werden. Durch eine geeignete Pr\u00e4ventionsstrategie w\u00e4re die gro\u00dfe Gefahr der Rezidivulzera geringer.<\/jats:p>","DOI":"10.1007\/s00104-020-01301-9","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T10:03:17Z","timestamp":1605002597000},"page":"81-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Diabetisches Fu\u00dfsyndrom \u2013 Teil\u00a01","Diabetic foot syndrome\u2014Part 1"],"prefix":"10.1007","volume":"92","author":[{"name":"Kommission PAVK und Diabetisches Fu\u00dfsyndrom der DGG e.\u202fV.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"R\u00fcmenapf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Rother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"G\u00f6rtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"B\u00f6ckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u2011A.","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hochlenert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3238\/arztebl.2016.0177","volume":"113","author":"T Tamayo","year":"2016","unstructured":"Tamayo\u00a0T, Brinks\u00a0R, Hoyer\u00a0A, Ku\u00df\u00a0O, Rathmann\u00a0W (2016) The prevalence and incidence of diabetes in Germany\u2014an analysis of statutory health insurance data on 65\u00a0million individuals from the years 2009 and 2010. Dtsch Arztebl Int 113:177\u2013182. https:\/\/doi.org\/10.3238\/arztebl.2016.0177","journal-title":"Dtsch Arztebl Int"},{"key":"1301_CR2","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","volume":"366","author":"AJM Boulton","year":"2005","unstructured":"Boulton\u00a0AJM, Vileikyte\u00a0L, Ragnarson-Tennvall\u00a0G, Apequist\u00a0J (2005) The global burden of diabetic foot disease. Lancet 366:1719\u20131724","journal-title":"Lancet"},{"key":"1301_CR3","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong\u00a0DG, Boulton\u00a0AJM, Bus\u00a0SA (2017) Diabetic foot ulcers and their recurrence. N\u00a0Engl J Med 376:2367\u20132375","journal-title":"N Engl J Med"},{"key":"1301_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13047-020-00383-2","author":"DG Armstrong","year":"2020","unstructured":"Armstrong\u00a0DG, Swerdlow\u00a0MA, Armstrong\u00a0AA, Conte\u00a0MS, Padula\u00a0WV, Bus\u00a0SA (2020) Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J\u00a0Foot Ankle Res. https:\/\/doi.org\/10.1186\/s13047-020-00383-2","journal-title":"J Foot Ankle Res"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","volume":"51","author":"L Prompers","year":"2008","unstructured":"Prompers\u00a0L, Schaper\u00a0N, Apelqvist\u00a0J et\u00a0al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51:747\u2013775","journal-title":"Diabetologia"},{"key":"1301_CR6","first-page":"B591","volume":"104","author":"H Bauer","year":"2007","unstructured":"Bauer\u00a0H, Germann\u00a0G, Gries\u00a0FA, Morbach\u00a0S, Riepe\u00a0G, Rothe\u00a0U, R\u00fcmenapf\u00a0G, Stiegler\u00a0H, Tepe\u00a0G, Uebel\u00a0T, Weck\u00a0M, Witte\u00a0M (2007) Nationale VersorgungsLeitlinie Typ-2-Diabetes \u2013 Pr\u00e4vention und Therapie von Fu\u00dfkomplikationen. Dtsch Arztebl 104:B591\u2013B598","journal-title":"Dtsch. Arztebl."},{"issue":"2","key":"1301_CR7","first-page":"181","volume":"12","author":"S Morbach","year":"2017","unstructured":"Morbach\u00a0S, M\u00fcller\u00a0E, Reike\u00a0H, Risse\u00a0A, R\u00fcmenapf\u00a0G, Spraul\u00a0M (2017) Diabetisches Fu\u00dfsyndrom. Diabetol Stoffwechs 12(2):181\u2013189","journal-title":"Diabetol Stoffwechs"},{"key":"1301_CR8","unstructured":"IWGDF (2019) 2019 IWGDF guidelines on the prevention and management of diabetic foot disease. www.iwgdfguidelines.org. Zugegriffen: 30.\u00a0Mai 2020"},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/CLEP.S146484","volume":"10","author":"H Claessen","year":"2018","unstructured":"Claessen\u00a0H, Narres\u00a0M, Haastert\u00a0B, Arend\u00a0W, Hoffmann\u00a0F, Morbach\u00a0S, R\u00fcmenapf\u00a0G, Kvitkina\u00a0T, Friedel\u00a0H, G\u00fcnster\u00a0C, Schubert\u00a0I, Ullrich\u00a0W, Westerhoff\u00a0B, Wilk\u00a0A, Icks\u00a0A (2018) Lower-extremity amputations in people with and without diabetes in Germany, 2008\u20132012\u2014an analysis of more than 30\u00a0million inhabitants. Clin Epidemiol 10:475\u2013488","journal-title":"Clin Epidemiol"},{"key":"1301_CR10","first-page":"130","volume":"114","author":"K Kr\u00f6ger","year":"2017","unstructured":"Kr\u00f6ger\u00a0K, Berg\u00a0C, Santosa\u00a0F, Malyar\u00a0N, Reinecke\u00a0H (2017) Lower limb amputation in Germany\u2014an analysis of data from the German federal statistical office between 2005 and 2014. Dtsch Arztebl Int 114:130\u2013136","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"1301_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4239\/wjd.v6.i3.391","volume":"6","author":"E Chantelau","year":"2015","unstructured":"Chantelau\u00a0E (2015) Nociception at the diabetic foot, an uncharted territory. World J Diabetes 6(3):391\u2013402","journal-title":"World J Diabetes"},{"key":"1301_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s001250051459","volume":"43","author":"P Holstein","year":"2000","unstructured":"Holstein\u00a0P, Ellitsgaard\u00a0N, Olsen\u00a0BB, Ellitsgaard\u00a0V (2000) Decreasing incidence of major amputations in people with diabetes. Diabetologia 43:844\u2013847","journal-title":"Diabetologia"},{"key":"1301_CR13","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song\u00a0P, Rudan\u00a0D, Zhu\u00a0Y, Fowkes\u00a0FJI, Rahimi\u00a0K, Fowkes\u00a0FGR, Rudan\u00a0I (2019) Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 7:e1020\u2013e1030","journal-title":"Lancet Glob Health"},{"key":"1301_CR14","unstructured":"IDF (2019) IDF diabetes Atlas. 9th edition 2019. https:\/\/www.diabetesatlas.org. Zugegriffen: 24.\u00a0April 2020"},{"key":"1301_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1464-5491.2008.02435.x","volume":"25","author":"A Samann","year":"2008","unstructured":"Samann\u00a0A, Tajiyeva\u00a0O, Muller\u00a0N, Tschauner\u00a0T, Hoyer\u00a0H et al (2008) Prevalence of the diabetic foot syndrome at the primary care level in Germany: a\u00a0cross-sectional study. Diabet Med 25:557\u2013563","journal-title":"Diabet Med"},{"issue":"8","key":"1301_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0182081","volume":"12","author":"M Narres","year":"2017","unstructured":"Narres\u00a0M, Kvitkina\u00a0T, Claessen\u00a0H, Droste\u00a0S, Schuster\u00a0B, Morbach\u00a0S, R\u00fcmenapf\u00a0G, Van Acker\u00a0K, Icks\u00a0A (2017) Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: a systematic review. PLoS ONE 12(8):1\u201328","journal-title":"PLoS ONE"},{"key":"1301_CR17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.2337\/dc15-0536","volume":"38","author":"O Hoffstad","year":"2015","unstructured":"Hoffstad\u00a0O, Nandita\u00a0M, Walsh\u00a0J, Margolis\u00a0DJ (2015) Diabetes, lower-extremity amputation, and death. Diabetes Care 38:1852\u20131857","journal-title":"Diabetes Care"},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1464-5491.1985.tb00588.x","volume":"2","author":"DR Williams","year":"1985","unstructured":"Williams\u00a0DR (1985) Hospital admissions of diabetic patients: information from hospital activity analysis. Diabet Med 2:27\u201332","journal-title":"Diabet. Med."},{"key":"1301_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist\u00a0E, K\u00e4r\u00e4j\u00e4m\u00e4ki\u00a0A, Martinell\u00a0M, Dorkhan\u00a0M, Carlsson\u00a0A, Vikman\u00a0P, Prasad\u00a0RB, Mansour Aly\u00a0D, Almgren\u00a0P, Wessmann\u00a0Y, Shaat\u00a0N, Spegel\u00a0P, Mulder\u00a0H, Lindholm\u00a0E, Melander\u00a0O, Hansson\u00a0O, Malmqvist\u00a0A, Lahti\u00a0K, Forsen\u00a0T, Tuomi\u00a0T, Rosengren\u00a0AH, Groop\u00a0L (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a\u00a0data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6:361\u2013369","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1301_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-43944-9","volume-title":"Das diabetische Fu\u00dfsyndrom \u2013 \u00dcber die Entit\u00e4t zur Therapie","author":"D Hochlenert","year":"2014","unstructured":"Hochlenert\u00a0D, Engels\u00a0G, Morbach\u00a0S (2014) Das diabetische Fu\u00dfsyndrom \u2013 \u00dcber die Entit\u00e4t zur Therapie. Springer, Berlin, Heidelberg"},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1111\/j.1464-5491.1991.tb02157.x","volume":"8","author":"AJ Boulton","year":"1991","unstructured":"Boulton\u00a0AJ (1991) Clinical presentation and management of diabetic neuropathy and foot ulceration. Diabet Med 8:S52\u201357","journal-title":"Diabet Med"},{"key":"1301_CR22","volume-title":"The diabetic charcot foot: principles and management","year":"2010","unstructured":"Frykberg\u00a0RG (Hrsg) (2010) The diabetic charcot foot: principles and management. Data Trace Publishing Company, Towson, MD"},{"key":"1301_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2337\/diacare.21.4.625","volume":"4","author":"E Faglia","year":"1998","unstructured":"Faglia\u00a0E, Favales\u00a0F, Quarantiello\u00a0A (1998) Angiographic evaluation of peripheral arterial occlusive disease and its role as a\u00a0prognostic determinant for major amputation in diabetic subjects with foot ulcer. Diabetes Care 4:625\u2013630","journal-title":"Diabetes Care"},{"key":"1301_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/00000658-199010000-00003","volume":"212","author":"FJ Veith","year":"1990","unstructured":"Veith\u00a0FJ, Gupta\u00a0SK, Wengerter\u00a0KR, Goldsmith\u00a0J, Rivers\u00a0SP, Bakal\u00a0CW, Dietzek\u00a0AM, Cynamon\u00a0J, Sprayregen\u00a0S, Gliedmann\u00a0ML (1990) Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia. Ann Surg 212:402\u2013412","journal-title":"Ann Surg"},{"key":"1301_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.119.040672","volume":"140","author":"JA Beckman","year":"2019","unstructured":"Beckman\u00a0JA, Duncan\u00a0MS, Damrauer\u00a0SM, Wells\u00a0QS, Barnett\u00a0JV, Wasserman\u00a0DH, Bedimo\u00a0RJ, Butt\u00a0AA, Marconi\u00a0VC, Sico\u00a0JJ, Tindle\u00a0HA, Bonaca\u00a0MP, Aday\u00a0AW, Freiberg\u00a0MS (2019) Microvascular disease, peripheral artery disease, and amputation. Circulation 140:449\u2013458","journal-title":"Circulation"},{"key":"1301_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/145749691210100207","volume":"101","author":"G J\u00f6rneskog","year":"2012","unstructured":"J\u00f6rneskog\u00a0G (2012) Why critical limb ischemia are not applicable to diabetic foot and what the consequences are. Scand J Surg 101:114\u2013118","journal-title":"Scand J Surg"},{"key":"1301_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/s-0029-1211335","volume":"103","author":"T Forst","year":"1995","unstructured":"Forst\u00a0T, Pfuetzner\u00a0A, Kann\u00a0P et al (1995) Association between diabetic autonomic C\u2011fibre neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions. Exp Clin Endocrinol Diabetes 103:94\u201398","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1301_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/PL00013177","volume":"23","author":"M Lundin","year":"1999","unstructured":"Lundin\u00a0M, Wiksten\u00a0JP, Per\u00e4kyla\u00a0T et\u00a0al (1999) Distal pulse palpation: is it reliable? World J Surg 23:252\u2013255","journal-title":"World J Surg"},{"issue":"95","key":"1301_CR29","first-page":"1","volume":"45","author":"H Lawall","year":"2016","unstructured":"Lawall\u00a0H, Huppert\u00a0P, Espinola-Klein\u00a0C, Zemmrich\u00a0C, R\u00fcmenapf\u00a0G (2016) S3-Leitlinie PAVK. Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. Vasa 45(95):1\u201396","journal-title":"Vasa"},{"key":"1301_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc07-2367","volume":"31","author":"P Ince","year":"2008","unstructured":"Ince\u00a0P, Zulfiquarali\u00a0GA, Lutale\u00a0JK, Basit\u00a0A, Mansour\u00a0AS, Chonan\u00a0F, Morbach\u00a0S, M\u00f6llenberg\u00a0J, Game\u00a0FL, Jeffcoate\u00a0WJ (2008) Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care 31:964\u2013967","journal-title":"Diabetes Care"},{"key":"1301_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","volume":"59","author":"JL Mills","year":"2014","unstructured":"Mills\u00a0JL, Conte\u00a0MS, Armstrong\u00a0DG, Pomposelli\u00a0FB, Schanzer\u00a0A, Sidawy\u00a0AN, Andros\u00a0G (2014) The society for vascular lower extremity threatened limb classicifation system: risk stratifcation based on wound, ischemia, and foot infection (WifI). J\u00a0Vasc Surg 59:220\u2013234","journal-title":"J Vasc Surg"},{"issue":"3","key":"1301_CR32","first-page":"42","volume":"39","author":"CA Behrendt","year":"2017","unstructured":"Behrendt\u00a0CA (2017) Treatment of peripheral arterial disease - when it becomes critical? Allgemeinarzt 39(3):42\u201347","journal-title":"Allgemeinarzt"},{"issue":"S1","key":"1301_CR33","doi-asserted-by":"publisher","first-page":"e3227","DOI":"10.1002\/dmrr.3237","volume":"36","author":"M Monteiro-Soares","year":"2020","unstructured":"Monteiro-Soares\u00a0M, Russell\u00a0D, Boyko\u00a0EJ, Jeffcoate\u00a0W, Mills\u00a0JL, Morbach\u00a0S, Game\u00a0F (2020) Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev 36(S1):e3227. https:\/\/doi.org\/10.1002\/dmrr.3237","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-020-01301-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T18:29:29Z","timestamp":1611253769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-020-01301-9"}},"subtitle":["Definition, Pathophysiologie, Diagnostik und Klassifikation","Definition, pathophysiology, diagnostics and classification"],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s00104-020-01301-9","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"10 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>G. R\u00fcmenapf:<\/b> A. Finanzielle Interessen: G. R\u00fcmenapf gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Chefarzt der Klinik f\u00fcr Gef\u00e4\u00dfchirurgie, Diakonissen Speyer, Diakonissen-Stiftungs-Krankenhaus Speyer. <b>S. Morbach:<\/b> A. Finanzielle Interessen: Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00e4.: Nationales Advisory Boards der Firmen Novo Nordisk sowie URGO GmbH, jeweils ein bis zwei ganzt\u00e4gige Treffen pro Jahr. \u2013 B. Nichtfinanzielle Interessen: Angestellter Diabetologe\/Angiologe (Chefarzt), Marienkrankenhaus Soest, Erm\u00e4chtigungsambulanz f\u00fcr Patienten mit Diabetischem Fu\u00dfsyndrom, Marienkrankenhaus Soest, Gastwissenschaftler Institut f\u00fcr Versorgungsforschung und Gesundheits\u00f6konomie Heinrich-Heine-Universit\u00e4t, D\u00fcsseldorf\u00a0| Mitgliedschaften: Deutsche Diabetes Gesellschaft (DDG, AG Diabetischer Fu\u00df), Europ\u00e4ische Diabetes Gesellschaft (EASD, Diabetic Foot Study Group), Deutsche Gesellschaft f\u00fcr Innere Medizin, Deutsche Gesellschaft f\u00fcr Angiologie, Deutsche Gesellschaft f\u00fcr Wundbehandlung und Wundheilung (DGfW), Nominating Committee als Past Vize-Pr\u00e4sident D\u2011Foot International. <b>U. Rother:<\/b> A. Finanzielle Interessen: U. Rother gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Oberarzt am Universit\u00e4tsklinikum Erlangen\u00a0| Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (DGG e.\u202fV.). <b>C. Uhl: <\/b>A. Finanzielle Interessen: Reise- und \u00dcbernachtungskosten sowie Teilnahmegeb\u00fchren: Fa. Cook, Medtronic, Gore. \u2013 B. Nichtfinanzielle Interessen: Oberarzt, Angestellter Gef\u00e4\u00dfchirurg, Klinik f\u00fcr Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Heidelberg\u00a0| Mitgliedschaft: DGG. <b>H. G\u00f6rtz:<\/b> A. Finanzielle Interessen: Referentenhonorar: Fa. NOWECOR. \u2013 F\u00fcr Tutoren- und Referentent\u00e4tigkeit im Rahmen endovaskul\u00e4rer Kurse: Fa. APIUM. \u2013 B. Nichtfinanzielle Interessen: Chefarzt Gef\u00e4\u00dfchirurgie, Bonifatiushospital Lingen\u00a0| Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (Leiter der Sektion f\u00fcr Endovaskul\u00e4re Techniken, Kommission pAVK und Diabetischer Fu\u00df). <b>D.\u00a0B\u00f6ckler:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: W.L. Gore & Ass.\u00a0| Siemens Healtheneers. \u2013 Honorar als Referent auf Kongressen: W.L, Gore & Ass, Medtronic, Siemens. \u2013 Wissenschaftlicher Berater: W.L Gore & Ass., Medtronic. \u2013 B. Nichtfinanzielle Interessen: \u00c4rztlicher Direktor der Klinik f\u00fcr Gef\u00e4\u00dfchirurgie und Endovaskul\u00e4re Chirurgie, Universit\u00e4tsklinikum Heidelberg\u00a0| Mitgliedschaften: Pr\u00e4sident der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin e.\u202fV. (2019\u20132020). <b>C.-A. Behrendt:<\/b> A. Finanzielle Interessen: Gef\u00f6rdert durch den Innovationsfond des Gemeinsamen Bundesausschusses (IDOMENEO, 01VSF16008 und RABATT, 01VSF18035). \u2013 B. Nichtfinanzielle Interessen: Oberarzt der Gef\u00e4\u00dfchirurgie in universit\u00e4rer Anstellung, Leiter der Forschungsgruppe GermanVasc, wissenschaftlicher Berater von benannten Stellen und Instituten bei der Evaluation von Richtlinien\u00a0| Chair des VASCUNET Committee, Chair des Medical Device Epidemiology Network (MDEpiNet) Chapter Germany\u00a0| Mitgliedschaften: Fellow Member der European Society for Vascular Surgery (ESVS), International Elected Member der Society for Vascular Surgery (SVS), PAVK und DFS Kommission der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (DGG), Editorial Board des European Journal of Vascular and Endovascular Surgery, Editorial Board der VASA European Journal of Vascular Medicine. <b>D. Hochlenert:<\/b> A. Finanzielle Interessen: D. Hochlenert gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Sebstst\u00e4ndiger Arzt in eigener diabetologischen Arztpraxis in K\u00f6ln. <b>G. Engels:<\/b> A. Finanzielle Interessen: G. Engels gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013 B. Nichtfinanzielle Interessen: Sebstst\u00e4ndiger Arzt in eigener chirurgischen Arztpraxis in K\u00f6ln. <b>M. Sigl:<\/b> A. Finanzielle Interessen: Referentenhonorare: Fa. Pfizer Pharma GmbH, Aspen GmbH. \u2013 Beraterhonorare: Bayer Vital GmbH, Rheacell GmbH & Co. KG. \u2013 B. Nichtfinanzielle Interessen: Angestellter Angiologe, Oberarzt, Leiter Bereich Angiologie, Universit\u00e4tsmedizin Mannheim\u00a0| Mitgliedschaften: DGIM, Deutsche Gesellschaft f\u00fcr Angiologie (DGA). <b>D.\u00a0Hochlenert<\/b> und <b>G.\u00a0Engels<\/b> geben an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}